The first gene-editing therapies for HIV/Aids are entering trials but the virus is proving once again that it is a master at ...
CRISPR technology, a revolutionary tool in genetic engineering, has empowered Lambert's iGEM team to tackle a significant health issue: Lyme disease, which affects nearly half a million Americans ...
A research team led by professor Olivia Merkel, Chair of Drug Delivery at LMU and co-spokesperson of the Cluster for Nucleic ...
Although existing CRISPR-Cas-based imaging methods can target endogenous genomic sequences, their applications are limited by system complexity and sensitivity, particularly when imaging ...
Scientists used CRISPR to disable the NRF2 gene, restoring chemotherapy sensitivity in lung cancer cells and slowing tumor ...
In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the NRF2 gene with CRISPR technology can reverse chemotherapy resistance in ...
Researchers used CRISPR to change the number of chromosomes in Arabidopsis by fusing chromosome arms, reducing the genome ...
Scientists used CRISPR to boost the efficiency and digestibility of a fungus already known for its meatlike qualities. The ...
The market offers strong growth potential driven by advancements in genetic engineering for efficient pharmaceutical protein ...
A new paper from the University of Kansas overturns the idea that a "risk gene" carried by millions of people worldwide ...
Outcomes validate the company’s PTAP platform as a foundation for a rapid, adaptable antiviral modality across animal and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results